MK-801 increases locomotor activity without elevating extracellular dopamine levels in the nucleus accumbens

Synapse

Volumn 24, Issue 2, 1996, Pages 135-146

  Druhan, Jonathan P ^a,b   Rajabi, Heshmat ^a   Stewart, Jane ^a  

^a and Applied Physiology   (Canada)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Amphetamine; Microdialysis; NMDA antagonist; PCP agonists

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; APOMORPHINE; DEXAMPHETAMINE; DIZOCILPINE; DOPAMINE; HOMOVANILLIC ACID;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG MECHANISM; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MICROSCOPIC ANATOMY; NERVE CELL STIMULATION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; DIZOCILPINE MALEATE; DOPAMINE; LOCOMOTION; MALE; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR;

EID: 0029819217     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199610)24:2<135::AID-SYN5>3.0.CO;2-G     Document Type: Article

References (71)

1. Akaoka, H., Charlety, P., Saunier, C.-F., Buda, M., and Chouvet, G. (1992) Inhibition of nigral dopamine neurons by systemic and local apomorphine: Possible contribution of dendritic autoreceptors. Neuroscience, 49:879-891.
2. Bristow, L.J., Hutson, P.H., Thorn, L., and Tricklebank M.D. (1993) The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents. Bri. J. Pharmacol., 108:1156-1163.
3. Carlezon, W.A. Jr. and Wise, R.A. (1993) Morphine-induced potentiation of brain stimulation reward is enhanced by MK-801. Brain Res., 620:339-342.
4. Carlsson, M. and Carlsson A. (1989) The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice. J. Neural Transm., 75:221-226.
5. Commissiong, J.W. (1985) Monoamine metabolites: Their relationship and lack of relationship to monoaminergic neuronal activity. Biochem. Pharmacol., 34:1127-1131.
6. Contreras, P.C., Contreras, M.L., O'Donohue, T.L., and Lair, C.C. (1988) Biochemical and behavioral effects of sigma and PCP ligands. Synapse, 2:240-243.
7. Corbett, D. (1989) Possible abuse potential of the NMDA antagonist MK-801. Behav. Brain Res., 34:239-246.
8. Corrigall, W.A. and Coen, K.M. (1991) Selective dopamine antagonists reduce nicotine self-administration. Psychopharmacology, 104: 171-176.
9. 1-dopamine receptor sensitization in neonatal 6-OHDA-lesioned rats is blocked by an NMDA receptor antagonist. Brain Res., 512:284-290.
10. Desce, J.M., Godeheu, G., Galli, T., Glowinski, J., and Cheramy, A. (1994) Opposite presynaptic regulations by glutamate through NMDA receptors of dopamine synthesis and release in rat striatal synaptosomes. Brain Res., 640:205-214.
11. Druhan, J.P., Jakob, A. and Stewart (1993) The development of behavioral sensitization to apomorphine is blocked by MK-801. Eur. J. Pharmacol., 243:73-77.
12. Fagg, G.E. (1987) Phencyclidine and related drugs bind to the activated N-methyl-D-aspartate receptor-channel complex in rat brain membranes. Neurosci. Lett., 76:221-227.
13. Ferris, R.M., Tang, F.L.M., and Maxwell, R.A. (1972) A comparison of the capacities of isomers of amphetamine, deoxypipadrol, and methylphenidate to inhibit the uptake of tritiated catecholamines into rat cerebral cortex slices, synaptosomal preparations of the rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of rabbit aorta. J. Pharmacol. Exp. Ther., 181:407-416.
14. Fischer, J.F. and Cho, A.K. (1979) Chemical release of dopamine from striatal homogenates: Evidence for an exchange diffusion model. J. Pharmacol. Exp. Ther., 208:203-209.
15. Ford, L.M., Norman, A.B., and Sanberg, P.R. (1989) The topography of MK-801-induced locomotor patterns in rats. Physiol. Behav., 46:755-758.
16. Foster, A.C. and Wong, E.H.F. (1987) The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain. Bri. J. Pharmacol., 91:403-409.
17. French, E.D. and Ceci, A. (1990) Non-competitive N-methyl-D-aspartate antagonists are potent activators of ventral tegmental A10 dopamine neurons. Neurosci. Lett., 119:159-162.
18. French, E.D., Ferkany, J., Abreu, M., and Levenson, S. (1991) Effects of competitive N-methyl-D-aspartate antagonists on midbrain dopamine neurons: An electrophysiological and behavioral comparison to phencyclidine. Neuropharmacology, 30:1039-1046.
19. French E.D., Mura, A., and Wang, T. (1993) MK-801, phencyclidine (PCP), and PCP-like drugs increase burst firing in rat A10 dopamine neurons: Comparison to competitive NMDA antagonists. Synapse, 13:108-116.
20. 3H-catecholamines by rat striatal and hypothalamic synaptosomes. Life Sci., 18:1105-1110.
21. Grace, A.A. and Bunney, B.S. (1985) Low doses of apomorphine elicit two opposing influences on dopamine cell electrophysiology. Brain Res., 333:285-298.
22. Hamilton, M.H., De Belleroche, J.S., Gardiner, I.M., and Herberg, L.J. (1986) Stimulatory effect of N-methyl aspartate on locomotor activity and transmitter release from rat nucleus accumbens. Pharmacol., Biochem. and Behav., 25:943-948.
23. Herberg, L.J. and Rose, I.C. (1989) The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward. Psychopharmacology, 99:87-90.
24. Hiramatsu, M., Cho, A.K., and Nabashima, T. (1989) Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine. Euro. J. Pharmacol., 166:359-366.
25. Hoffman, D.C. (1992) Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats. J. Neural Transm., 89:1-10.
26. Jones, S.M., Snell, L.D., and Johnson, K.M. (1987) Inhibition by phencyclidine of excitatory amino acid-stimulated release of neurotransmitter in the nucleus accumbens. Neuropharmacology, 26:173-179.
27. Kalivas, P.W. and Stewart, J. (1991) Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev., 16:223-244.
28. Karler, R., Calder, L.D., Chaudry, I.A., and Turkanis, S.A. (1989) Blockade of 'reverse tolerance' to cocaine and amphetamine by MK-801. Life Sci., 45:599.
29. Karler, R., Calder, L.D., Chaundry, I.A., and Turkanis, S.A. (1990) Amphetamine behavioral sensitization and the excitatory amino acids. Brain Res., 537:76-82.
30. Kelley, A.E. and Throne, L.C. (1992) NMDA receptors mediate the behavioral effects of amphetamine infused into the nucleus accumbens. Brain Res. Bull., 29:247-254.
31. Koek, W., Woods, J.H., and Winger, G.D. (1988) MK-801, a proposed noncompetitive antagonist of excitatory amino acids neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. J. Pharmacol. Exp. Ther., 245:969-974.
32. Layer, R.T., Kaddis, F.G., and Wallace, L.J. (1993) The NMDA receptor antagonist MK-801 elicits conditioned place preference in rats. Pharmacol. Biochem. Behav., 44:245-247.
33. Liljequist, S., Ossowska, K., Grabowska-Anden, M., and Anden, N.E. (1991) Effect of the NMDA receptor antagonist, MK-801, on locomotor activity and on the metabolism of dopamine in various brain areas of mice. Eur. J. Pharmacol., 195:55-61.
34. Loscher, W. and Honack, D. (1991) The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: Attenuation by manipulation of dopamine, alpha-1 and serotonin 1A receptors. J. Pharmacol. Exp. Ther., 257:1146-1153.
35. Loscher, W., Annies, R., and Honack, D. (1991) The N-methyl-D-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats. Neurosci. Lett., 128:191-194.
36. Maj, J., Rogoz, Z., and Skuza, G. (1991) Locomotor hyperactivity induced by MK-801 in rats. Pol. J. Pharmacol. Pharm., 43:449-458.
37. Morelli, M. and Di Chiara, G. (1990) Stereospecific blockade of N-methyl-D-aspartate transmission by MK 801 prevents priming of SKF 38393-induced turning. Psychopharmacology, 101:287-288.
38. Murase, S., Mathe, J.M., Grenhoff, J., and Svensson, T.H. (1993) Effects of dizocilpine (MK-801) on rat midbram dopamine cell activity: Differential actions on firing pattern related to anatomical localization. J. Neural Transm., 91:13-25.
39. Museo, E. and Wise, R.A. (1990) Locomotion induced by ventral tegmental microinjections of a nicotinic agonist. Pharmacol. Biochem. Behav., 35:735-737.
40. Ouagazzal, A., Nieoullon, A., and Amalric, M. (1993) Effects of dopamine D1 and D2 receptor blockade on MK-801-induced hyperlocomotion in rats. Psychopharmacology, 111:427-434.
41. Ouagazzal, A., Nieoullon, A., and Amalric, M. (1994) Locomotor activation induced by MK-801 in the rat: Postsynaptic interactions with dopamine receptors in the ventral striatum. Eur. J. Pharm., 251:229-236.
42. Pawlowski, L., Mathe, J.M., and Svensson, T.H. (1990) Phencyclidine activates rat A10 dopamine neurons but reduces burst activity and causes regularization of firing. Acta Physiol. Scand., 139:529-530.
43. Pellegrino, L.J., Pellegrino, A.S., and Cushman, A.J. (1979) A Stereotaxic Atlas of the Rat Brain. Plenum, New York.
44. Pulvirenti, L., Swerdlow, N. and Koob, G.F. (1991) Nucleus accumbens NMDA antagonist decreases locomotor activity produced by cocaine, heroin or accumbens dopamine, but not caffeine. Pharmacol. Biochem. Behav., 40:841-845.
45. Pulvirenti, L., Maldonado-Lopez, R., and Koob, G.F. (1992) NMDA receptors in the nucleus accumbens modulate intravenous cocaine but not heroin self-administration in the rat. Brain Res., 594:327-330.
46. Rao, T.S., Kim, H.S., Lehmann, J., Martin, L.L., and Wood. P.L. (1990) Interactions of phencyclidine receptor agonist MK-801 with dopaminergic system: Regional studies in the rat. J. Neurochem., 54:1157-1162.
47. Rossetti, Z.L., Hmaidan, Y., and Gessa, G.L. (1992) Marked inhibition of mesolimbic dopamine release: A common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur. J. Pharmacol., 221:227-234.
48. Rothman, R.B., Reid, A.A., Monn, J.A., Jacobson, A.E., and Rice, K.C. (1989) The psychotomimetic drug phencyclidine labels two high affinity binding sites in guinea pig brain: Evidence for N-methyl-D-aspartate-coupled and dopamine reuptake carrier-associated phencyclidine binding sites. Mol. Pharmacol., 36:887-896.
49. Segal, D.S., Kuczenski, R., and Florin, S.M. (1995) Does dizocilpine (MK-801) selectively block the enhanced responsiveness to repeated amphetamine administration. Behav. Neurosci., 109:532-546.
50. 3H-serotonin uptake in synaptosomal preparations from rat brain. Biochem. Pharmacol., 26:1435-1439.
51. Snell, L.D., Yi, S.J., and Johnson, K.M. (1988) Comparison of the effects of MK-801 and phencyclidine on catecholamine uptake and NMDA-induced norepinephrine release. Eur. J. Pharmacol., 145:223-226.
52. Stewart, J. and J.P. Druhan (1993) Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist MK-801. Psychopharmacology, 110:125-132.
53. Stewart, J., de Wit, H., and Eikelboom, R. (1984) Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants. Psychol. Rev., 91:211-227.
54. Svensson, A. and Carlsson, M.L. (1992) Injection of the competitive NMDA receptor antagonist AP-5 into the nucleus accumbens of monoamine-depleted mice induces pronounced locomotor stimulation. Neuropharmacology, 31:513-518.
55. Svensson, A., Pilebald, E., and Carlason, M. (1991) A comparison between the non-competitive NMDA antagonist dizocilpine (MK-801) and the competitive NMDA antagonist D-CPPene with regard to dopamine turnover and locomotor-stimulatory properties in mice. J. Neural Transm., 85:117-129.
56. Tanii, Y., Nishikawa, T., Umino, A., and Takahashi K. (1990) Phencyclidine increases extracellular dopamine metabolites in rat medial frontal cortex as measured by in vivo dialysis. Neurosci. Lett., 112:318-323.
57. Tiedtke, P.I., Bischoff, C., and Schmidt, W.J. (1990) MK-801-induced stereotypy and its antagonism by neuroleptic drugs. J. Neural Transm., 81:173-182.
58. Tricklebank, M.D., Singh, L., Oles, R.J., Preston, C., and Iversen, S.D. (1989) The behavioural effects of MK-801: A comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Eur. J. Pharmacol., 167:127-135.
59. Verma, A. and Kulkarni, S.K. (1992) Modulation of MK-801 response by dopaminergic agents in mice. Psychopharmacology, 107:431-436.
60. 3H-dopamine accumulation by rat brain striatal slices. Substance Alcohol Actions/Misuse, 1:351-354.
61. Wedzony K., Klimek, V., and Golembiowska, K. (1993) MK-801 elevates the extracellular concentration of dopamine in the rat prefrontal cortex and increases the density of striatal dopamine D1 receptors. Brain Res., 622:325-329.
62. Weihmuller, F.B., O'Dell, S.J., Cole, B.N., and Marshall, J.F. (1991) MK-801 attenuates the dopamine-releasing but not the behavioral effects of methamphetamine: An in vivo microdialysis study. Brain Res., 549:230-235.
63. Willins, D.L., Narayanan, S., Wallace, L.J., and Uretsky, N.J. (1993) The role of dopamine and AMPA/kainate receptors in the nucleus accumbens in the hypermotility response to MK-801. Pharmacol. Biochem. Behav., 46:881-887.
64. Wise, R.A. and Bozarth, M.A. (1987) A psychomotor stimulant theory of addiction. Psychol. Rev., 94:469-492.
65. Wolf, M.E. and Khansa, M.R. (1991) Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine. Brain Res., 562:164-168.
66. Wolf, M.E., White, F.J., and Hu, X.T. (1994a) MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine. J. Neurosci., 14:1735-1745.
67. Wolf, M.E., Xue, C.-J., White, F.J., and Dahlin, S.L. (1994b) MK-801 does not prevent acute stimulatory effects of amphetamine or cocaine on locomotor activity or extracellular dopamine levels in rat nucleus accumbens. Brain Res., 666:223-231.
68. Yang, Q., Moroji, T., Takamatsu, Y., Hagino, Y., and Okuwa, M. (1991) The effects of intraperitoneally administered phencyclidine on the central nervous system: Behavioral and neurochemical studies. Neuropeptides, 19:77-90.
69. Youngren, K.D., Daly, D.A., and Moghaddam, B. (1993) Distinct actions of endogenous excitatory amino acids on the outflow of dopamine in the nucleus accumbens. J. Pharmacol. Exp. Ther., 264:289-293.
70. Zhang, J., Chiodo, L.A., and Freeman, A.S. (1992) Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons. Brain Res., 590:153-163.
71. Zhang, J., Chiodo, L.A., and Freeman, A.S. (1993) Effects of phencyclidine, MK-801 and 1,3-di(2- tolyl)guanidine on non-dopaminergic midbrain neurons. Eur. J. Pharmacol., 230:371-374.